
Continuing resolutions, program cancellations, and multi-year acquisition cycles keep defense revenue lumpy no matter how good your product is. We build growth strategies that hold up under that volatility and turn government relationships into durable revenue.
Government budget volatility destroys growth predictability
Aerospace companies build multi-year growth plans that collapse the moment a continuing resolution stalls new starts or a program loses political support. You can't forecast next year's revenue when your largest customer's budget is set by a process outside your control. Commercial aerospace companies with diversified revenue keep growing through the same cycles that stall single-customer defense suppliers. The gap isn't product quality – it's revenue concentration.
Long development cycles require sustained investment without revenue
Defense technology development routinely runs 3-7 years from concept to fielded system, which means sustained R&D spend with no revenue to offset it. Most aerospace companies run out of cash mid-development or get acquired before the technology pays off. A growth plan borrowed from software assumes cash comes back in quarters, not years. Without a financing plan built around the real timeline, a technically successful program can still sink the company that built it.
Industry consolidation limits customer diversification
Prime contractor consolidation has shrunk the list of companies a supplier can sell to and concentrates your risk in a handful of relationships. Small and mid-size aerospace companies get squeezed out of supply chains or forced into subcontractor terms that erode margin. Your growth now depends on primes who may view you as an acquisition target one year and a competitive threat the next. That dynamic makes independent, sustainable growth harder every year consolidation continues.
We start by mapping your current revenue against risk: which programs, agencies, and primes you depend on, and how exposed each is to budget or political shifts. Most aerospace companies over-index on one program or one customer relationship and don't find out how exposed they are until a budget line gets cut. We build that map first so diversification decisions are based on actual concentration, not intuition.
Strategy development focuses on building a revenue portfolio that pairs government contract work with more predictable commercial or adjacent-market revenue. That means identifying real commercial applications for defense-funded technology, evaluating international opportunities where export controls allow it, and structuring partnerships that hold up when a single government budget cycle turns against you. We also build the cash flow model your finance team needs to survive a multi-year development timeline without guessing.
Execution means putting systems in place, not just handing over a deck. We build opportunity tracking that watches program health 18-36 months out – well before a budget cut shows up in your pipeline – partnership development processes that open new market access, and a technology roadmap that ties R&D spend to where the market is actually going. The goal is a growth plan that survives a change in your VP of BD or a shift in budget priorities at the top.
Measurement tracks financial performance and strategic exposure together: revenue diversification progress, pipeline health across programs, and R&D-to-commercial-revenue conversion. We use that data to adjust the plan on a real cadence instead of revisiting strategy once a year, because aerospace market conditions shift faster than an annual planning cycle can absorb.
Most aerospace companies optimize for winning the next contract when they should be optimizing for surviving the loss of any one contract. Portfolio resilience, not contract volume, is what keeps a defense supplier growing through a budget cycle.
Our aerospace growth methodology runs a 90-day portfolio resilience process. Phase one is a current-position audit: revenue concentration by program and agency, customer dependency, and where you actually stand against competitors chasing the same primes. Phase two builds the diversification and growth strategy, targeting markets where your existing technical capability transfers instead of chasing unrelated opportunities. Phase three stands up the tracking and measurement systems that keep the plan alive after the engagement ends.
This differs from generic growth consulting because it treats budget volatility, long development timelines, and prime consolidation as constraints to design around, not noise to explain away later.
Days 1-30 are strategic assessment: we analyze current revenue streams, competitive position, and the specific growth constraints your programs face. Days 30-60 are strategy development and partnership mapping – we work directly with your technical leads to find commercialization angles and with finance to build the cash flow model for sustained development spend. The final 30 days stand up the growth systems and measurement cadence your team runs going forward. Most engagements run 6-12 months to see a strategic initiative through to execution, with extensions tied to specific market development milestones, not calendar renewals. Our team has worked inside aerospace and defense organizations, not applied a generic framework to a market it doesn't fit.
If your aerospace & defense company needs growth strategy leadership, we should talk.

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Aerospace growth strategy engagements typically run $25K-60K per month, depending on how many markets you're evaluating and how complex the diversification work is. That's well under the cost of a senior strategy executive with real aerospace experience, who commands $180K+ in salary alone before benefits and equity. International expansion or export-controlled technology work pushes cost toward the higher end due to the added compliance review. Most clients see the investment pay back through better contract margins and lower concentration risk within the first year.
Strategic positioning and partnership development show visible progress within 90 days, but real revenue diversification typically takes 12-18 months given how long aerospace sales cycles run. Technology commercialization into a new market can take 18-36 months depending on certification and regulatory requirements in that market. The fastest wins usually come from restructuring how you pursue existing opportunities rather than from breaking into a brand-new market.
We work directly with your executive team, business development staff, and technical leadership so the strategy reflects real capabilities, not assumptions. Bi-weekly sessions review progress against the growth plan and flag any program or budget changes that require an adjustment. Monthly leadership reviews track the key metrics and reset priorities if a market shifts. Our team has worked inside aerospace and defense organizations, so the sessions run on your industry's terms, not a generic consulting framework.
Most strategy consultants bring a commercial playbook and force it onto a market with government budget cycles, ITAR restrictions, and consolidation pressure it wasn't built for. We start from those constraints instead of working around them. Our target is long-term market resilience, not a quarter of revenue growth that evaporates when one contract ends. We measure success by whether your customer concentration actually went down, not just by whether revenue went up.
We track strategic exposure metrics – revenue diversification, customer concentration – alongside financial outcomes like revenue growth, margin improvement, and cash flow stability. Specific measurements include market penetration in new segments, partnership conversion rate, and how much R&D spend is converting into commercial revenue. We connect those strategic moves to the financial numbers directly so you can see which initiatives are actually driving the outcome, not just correlating with it.
Companies with proven technology and real R&D capability, generally in the $5M-100M revenue range, who win individual contracts but can't turn that into predictable growth. If you're carrying more than a third of your revenue in one program or one customer relationship and want to change that before the next budget cycle forces the issue, this is built for you. The clearest signal you're a fit: you can win the next contract but you can't confidently forecast the year after it.
Tuesday, September 15, 2026
Frank Growth – Episode 237 – Stop Buying Users Who Leave with Michelle Matthews
Tuesday, September 8, 2026
Frank Growth – Episode 236 – Turn Marketers Into AI Strategists with Elyssa Steiner
Tuesday, June 16, 2026
Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy
Tuesday, July 21, 2026
Frank Growth – Episode 229 – Longevity Medicine’s Dirty Secret with Jim Donnelly
Ready to unlock your growth?
Book Free Call